Two scholarship chemistry majors order a supposedly advanced party drug from a clinical-looking dark web market and use their training to analyse its changing composition. As euphoria gives way to paranoia, hallucinations, and hidden surveillance, they discover that anonymous buyers are paying to turn their decline into an interactive human trial.